EHC
Encompass Health Corporation
$126.04
+$1.98(+1.60%)
67
Overall
80
Value
54
Tech
--
Quality
Market Cap
$12.47B
Volume
626.30K
52W Range
$87.85 - $127.15
Target Price
$137.42
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $3.2B | $3.7B | $3.9B | $4.3B | $4.6B | $4.6B | $4.0B | $4.3B | $4.8B | $5.4B | ||
| Total Revenue | $3.2B | $3.6B | $3.9B | $4.3B | $4.6B | $4.6B | $4.0B | $4.3B | $4.8B | $5.4B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-2.6B | $-3.0B | $-3.3B | $-3.6B | $-82.3M | $171.0M | $184.2M | $202.1M | $218.3M | $3.1B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $3.2B | $3.7B | $3.9B | $4.3B | $4.7B | $3.4B | $3.8B | $4.1B | $4.8B | $2.2B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $2.6B | $3.1B | $3.3B | $3.6B | $3.8B | $3.9B | $3.3B | $3.5B | $4.0B | $4.5B | ||
| Research & Development | $7.5M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Selling, General & Administrative | $318.9M | $346.6M | $394.5M | $456.9M | $414.9M | $356.0M | $353.7M | $356.4M | $420.0M | $448.2M | ||
| Selling & Marketing Expenses | $-7.3M | $-7.5M | $-6.3M | $-6.7M | $167.9M | $200.5M | $184.2M | $202.1M | $218.3M | $239.0M | ||
| General & Administrative Expenses | $318.9M | $346.6M | $394.5M | $456.9M | $247.0M | $155.5M | $169.5M | $154.3M | $201.7M | $209.2M | ||
| Promotion & Advertising | $-7.3M | $-7.5M | $-6.3M | $-6.7M | $6.1M | $4.6M | $5.6M | -- | -- | -- | ||
| Salaries & Wages | $1.7B | $2.0B | $2.2B | $2.4B | $2.6B | $2.7B | $2.1B | $2.4B | $2.6B | $2.9B | ||
| Depreciation & Amortization | $139.7M | $172.6M | $183.8M | $199.7M | $218.7M | $243.0M | $219.6M | $243.6M | $273.9M | $299.6M | ||
| Depreciation & Amortization | $139.7M | $172.6M | $183.8M | $199.7M | $218.7M | $243.0M | $219.6M | $243.6M | $273.9M | $299.6M | ||
| Amortization | $-48.7M | $-70.3M | $-72.0M | $-51.4M | $2.3B | $2.4B | $1.3B | $1.3B | $1.3B | $1.3B | ||
| Other Operating Expenses | $479.3M | $553.3M | $531.6M | $585.1M | $623.6M | $634.4M | $595.9M | $670.4M | $719.1M | $802.6M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $554.2M | $648.8M | $649.4M | $681.6M | $857.1M | $810.2M | $777.4M | $684.9M | $788.1M | $921.8M | ||
| EBITDA | $692.5M | $840.5M | $843.3M | $844.2M | $945.2M | $739.6M | $1.0B | $879.8M | $1.0B | $1.2B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $142.9M | $172.1M | $154.4M | $147.3M | $159.7M | $183.7M | $164.3M | $175.7M | $143.5M | $137.4M | ||
| Interest Income Operating | $9.4M | $9.7M | $4.6M | -- | -- | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-142.9M | $-172.1M | $-154.4M | $-147.3M | $-159.7M | $-184.2M | $-164.3M | $-175.7M | $-39.7M | $-39.9M | ||
| Gain on Sale of Securities | $1.2M | $3.3M | -- | $600.0K | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $8.2M | $-5.3M | $-1.4M | $-10.9M | $-29.5M | $-11.8M | $-9.9M | $-3.7M | $-18.9M | $-22.5M | ||
| Other Special Charges | $-16.9M | $-4.5M | $-6.6M | $2.2M | $22.8M | $8.3M | $6.5M | $-6.6M | $15.7M | $19.5M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | $-301.8M | $-360.8M | $-284.8M | $-415.3M | -- | -- | -- | ||
| Special Income Charges | $-7.5M | $14.3M | -- | $-52.0M | $360.8M | $-2.8M | $415.3M | $273.7M | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $538.5M | $654.1M | $650.8M | $640.5M | $722.0M | $536.6M | $787.3M | $626.5M | $750.7M | $887.0M | ||
| Pre-Tax Income | $395.6M | $482.0M | $496.4M | $493.2M | $562.3M | $472.6M | $505.0M | $450.8M | $607.2M | $749.6M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $141.9M | $163.9M | $145.8M | $118.9M | $115.9M | $74.7M | $101.9M | $100.1M | $132.2M | $150.2M | ||
| NET INCOME | ||||||||||||
| Net Income | $183.1M | $247.6M | $271.1M | $292.3M | $358.7M | $284.2M | $412.2M | $271.0M | $352.0M | $455.7M | ||
| Net Income (Continuing Operations) | $183.1M | $247.6M | $271.1M | $292.3M | $358.7M | $284.2M | $521.1M | $350.7M | $475.0M | $599.4M | ||
| Net Income (Discontinued Operations) | $183.1M | $247.6M | $271.1M | $292.3M | $358.7M | $284.2M | $412.2M | $271.0M | $352.0M | $455.7M | ||
| Net Income (Common Stockholders) | $181.5M | $247.6M | $271.1M | $292.3M | $523.3M | $283.2M | $410.4M | $269.8M | $352.0M | $452.9M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | $479.7M | $742.1M | ||
| TOTALS | ||||||||||||
| Total Expenses | $39.7M | $61.2M | $52.4M | $-52.0M | $3.7B | $3.8B | $3.5B | $3.7B | $4.0B | $7.6B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $89.4M | $89.1M | $93.7M | $97.9M | $98.0M | $98.6M | $99.0M | $99.2M | $99.5M | $99.9M | ||
| Average Shares Outstanding (Diluted) | $101.0M | $99.5M | $99.3M | $99.8M | $99.4M | $99.8M | $100.2M | $100.4M | $101.3M | $102.2M | ||
| Shares Outstanding | $89.8M | $89.1M | $98.1M | $98.7M | $98.4M | $99.3M | $99.4M | $99.7M | $100.1M | $100.7M | ||
| Basic EPS | $2.02 | $2.77 | $2.88 | $2.98 | $3.65 | $2.87 | $4.15 | $2.72 | $3.51 | $1.2 | ||
| Basic EPS (Continuing Operations) | $2.03 | $2.77 | $2.88 | $2.97 | $3.66 | $2.87 | $4.15 | $2.58 | $3.63 | $4.56 | ||
| Diluted EPS | $1.91 | $2.59 | $2.84 | $2.93 | $3.61 | $2.85 | $4.11 | $2.7 | $3.47 | $4.46 | ||
| Diluted EPS (Continuing Operations) | $1.92 | $2.59 | $2.84 | $2.92 | $3.62 | $2.85 | $4.11 | $2.56 | $3.59 | $4.49 | ||
| Dividend Per Share | $0.88 | $0.94 | $0.98 | -- | $1.1 | $1.12 | $1.12 | $0.86 | $0.60 | $0.64 | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | $1.6M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | $-0.01 | -- | -- | $0.01 | $-0.01 | -- | -- | $0.14 | $-0.12 | $-0.03 | ||
| Development Expense | $7.5M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Diluted Discontinuous Operations | $-0.01 | -- | -- | $0.01 | $-0.01 | -- | -- | $0.14 | $-0.12 | $-0.03 | ||
| Earnings from equity interest | $8.7M | $9.8M | $8.0M | $8.7M | $6.7M | $3.5M | $3.4M | $2.9M | $3.2M | $3.0M | ||
| Earnings From Equity Interest Net Of Tax | $8.7M | $9.8M | $8.0M | $8.7M | $6.7M | $3.5M | $3.4M | $2.9M | $3.2M | $3.0M | ||
| Gains Loss On Disposal Of Discontinued Operations | $-900.0K | -- | $-400.0K | $1.1M | -- | -- | -- | -- | -- | -- | ||
| Marketing Expense | $3.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | $-69.7M | $-70.5M | $-79.1M | $-83.1M | $-87.1M | $-84.6M | $-105.0M | $-94.9M | $-111.0M | $-140.9M | ||
| Net Income Discontinuous Operations | $-900.0K | $300.0K | $-400.0K | $1.1M | $-600.0K | -- | $114.1M | $15.2M | $-12.0M | $-2.8M | ||
| Non Recurring Operation Expense | $7.5M | -- | -- | $52.0M | -- | $2.8M | -- | -- | -- | -- | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | -- | $-600.0K | -- | $114.1M | $15.2M | $-12.0M | $-2.8M | ||
| Other Gand A | $318.9M | $346.6M | $394.5M | $456.9M | $247.0M | $155.5M | $169.5M | $154.3M | $201.7M | $209.2M | ||
| Other Write Off | $-18.6M | $-29.4M | $-42.7M | -- | -- | -- | -- | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | $1.6M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $1.6M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $187.2M | $204.7M | $245.2M | $298.2M | $82.3M | -- | -- | -- | -- | -- | ||
| Write Down | -- | $-14.3M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | $53.9M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | $-301.8M | $-360.8M | $-284.8M | $-415.3M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EHC | $126.04 | +1.6% | 626.30K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Encompass Health Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW